The immunoexpression of the tumor we described, the negativity for GATA3, and the morphology of the lesion may suggest that such tumors could possibly be assigned to squamous cell carcinomas, but possess a peculiar morphology and growth characteristics that should be further investigated in the context of potential clinical applications. This evidence concerns the gene GATA3 and squamous cell carcinoma.